top of page

Pharmaceuticals - Regulatory Performance

Get Updates!


Review Times At a Glance

New Drug Applications



Percentage of Cleared 510(k)s Based on Year Submitted

Data as of 1 July 2019


In general, review times ...


510k Review Time Type 2018 & 2019 YTD -

510(k) Review Time by Review Committee

All 510(k) Types

What Review Committee?  

Review times can vary based on the Review Committee.

In both 2017 and 2018, Anesthesiology and Molecular Genetics groups had the highest review times.  Radiology, Microbiology, and Ophthalmology had the shortest review times.

501K Review Time by Comm 2018&2019 YTD -

De Novo Reviews

Review Times At a Glance

De Novo reviews are generally longer than 510(k)s.  Over time, the review times have decreased, but the average is still closer to what we see with original PMAs.

Most are submitted directly, although there are still a few that are Post-NSE.

Less than half of De Novo submissions logged in are eventually approved.  The longer review times mean that we wait longer to really see the success rate.




Percentage of Approved De Novo Based on Year Submitted

Data as of 1 July 2019

De Novo Review Time by Type 2017-2019 YT

De Novo Review Times by Reviewing Committee

De Novo Review Time Comm 2017-2019YTD -

Review times for De Novo submissions can vary greatly between reviewing committees.  

Note that in 2018, one outlier (DEN070001) in MI, drives their average higher.  Without the outlier, MI had an average review time in 2018 of 207 days.

Review Times At a Glance

Premarket Approvals




Percentage of Approved original PMAs Based on Year Submitted

Data as of 1 July 2019

Average review days for original PMAs increased to 465 days in 2018 from 354 days in 2017.

Panel Track Supplement review days also rose in 2018.  The rest of supplement types have stayed fairly consistent year over year.

PMA Review Time by Type 2017-2019 YTD -

Original PMA Review Times by Advisory Committee 2017 to 2019 YTD

PMA Orig Review Days Comm 2017-2019 YTD

Review times increased for CV, SU, and OR.  Reviews in CH, TX and GU were higher than the 2017 average, raising the overall average review time 111 days.

De Novo Review Days Distribution

Say something here

about this graphic

Reasons for PMA Supplements

Process changes are the most frequent reason for a PMA supplement, followed by a design change.

PMA Suppl Reasons 2017-2019 YTD - 2019-0

What other metric would you like to see?

bottom of page